Matthias Nettekoven

1.1k citations

35 papers · 663 indexed · h-index 17

Co-authors: Gisbert Schneider Wolfgang Guba Andrew W. Thomas Henner Knust Olivier Roche Sébastien Schmitt Mark Rogers‐Evans Werner Neidhart
Topics: Receptor Mechanisms and Signaling (12 papers)Synthesis and Biological Evaluation (7 papers)Chemical Synthesis and Analysis (6 papers)
Cited by: Endocrine and Autonomic Systems Organic Chemistry Pharmaceutical Science
Journals: Angewandte Chemie International Edition Chemical Communications Journal of Medicinal Chemistry
Partner nations: Switzerland Germany Canada

In The Last Decade

Matthias Nettekoven

35 papers receiving 644 citations

Peers

Countries citing papers authored by Matthias Nettekoven

Since Specialization

Citations

This map shows the geographic impact of Matthias Nettekoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Nettekoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Nettekoven more than expected).

Fields of papers citing papers by Matthias Nettekoven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Nettekoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Nettekoven. The network helps show where Matthias Nettekoven may publish in the future.

Co-authorship network of co-authors of Matthias Nettekoven

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Nettekoven. A scholar is included among the top collaborators of Matthias Nettekoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Nettekoven. Matthias Nettekoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges and Rewards in Medicinal Chemistry Targeting Cardiovascular and Metabolic Diseases 2015 ·CHIMIA International Journal for Chemistry ·Werner Neidhart,Tanja Schulz‐Gasch,A. Ruf,Matthias Nettekoven,Hans Peter Märki,Bernd Kuhn,Daniel Hunziker,(unknown),Kurt E. Amrein,(unknown),A. Mayweg	1
2	Conformationally restricted pyrrolidines by intramolecular [2+2] photocycloaddition reactions 2013 ·Chemical Communications ·Diego A. Fort,Thomas J. Woltering,Matthias Nettekoven,Henner Knust,Thorsten Bach	14
3	Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening 2013 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Nettekoven,Jürgen Fingerle,Uwe Grether,Sabine Grüner,(unknown),(unknown),Mark Rogers‐Evans,Stephan Röver,Franz Schuler,Tanja Schulz‐Gasch,Christoph Ullmer	12
4	Synthesis of Fluorinated Tricyclic Scaffolds by Intramolecular [2+2] Photocycloaddition Reactions 2012 ·Angewandte Chemie International Edition ·Diego A. Fort,Thomas J. Woltering,Matthias Nettekoven,Henner Knust,Thorsten Bach	29
5	Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Hassen Ratni,Theresa M. Ballard,Caterina Bissantz,Torsten Hoffmann,(unknown),Frédéric Knoflach,Henner Knust,P. Malherbe,Matthias Nettekoven,(unknown),Claus Riemer,Monique Schmitt,Will Spooren	6
6	Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold 2010 ·Bioorganic & Medicinal Chemistry Letters ·Hans Richter,Christian Freichel,Jörg Huwyler,Tatsuo Nakagawa,Matthias Nettekoven,Jean‐Marc Plancher,S. Raab,Olivier Roche,Franz Schuler,Sven Taylor,Christoph Ullmer,(unknown)	21
7	Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX₂ receptor 2009 ·British Journal of Pharmacology ·P. Malherbe,Edilio Borroni,Luca Gobbi,Henner Knust,Matthias Nettekoven,Emmanuel Pinard,Olivier Roche,Mark Rogers‐Evans,(unknown),J‐L Moreau	72
8	Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Olivier Roche,Matthias Nettekoven,(unknown),(unknown)	12
9	Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Emmanuel Pinard,Daniela Alberati,Edilio Borroni,Holger Fischer,Dominik Hainzl,Synèse Jolidon,Jean‐Luc Moreau,Robert Narquizian,Matthias Nettekoven,Roger D. Norcross,Henri Stalder,Andrew W. Thomas	18
10	Aminothiazole Derivatives as Neuropeptide Y5 Receptor Ligands: Finding the Balance between Affinity and Physicochemical Properties 2005 ·ChemMedChem ·Matthias Nettekoven,Wolfgang Guba,Werner Neidhart,Patrizio Mattei,Philippe Pflieger,Jean‐Marc Plancher,Sven Taylor	10
11	Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design 2005 ·Bioorganic & Medicinal Chemistry Letters ·Wolfgang Guba,Werner Neidhart,Matthias Nettekoven	25
12	Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Nettekoven,Wolfgang Guba,Werner Neidhart,Patrizio Mattei,Philippe Pflieger,Olivier Roche,Sven Taylor	10
13	Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities? 2004 ·Bioorganic & Medicinal Chemistry Letters ·Wolfgang Guba,Matthias Nettekoven,(unknown),Claus Riemer,Sébastien Schmitt	19
14	Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process 2003 ·Combinatorial Chemistry & High Throughput Screening ·Alexander Alanine,Matthias Nettekoven,Edward Roberts,Andrew W. Thomas	38
15	Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow 2002 ·Current Medicinal Chemistry ·Matthias Nettekoven,Andrew W. Thomas	16
16	The Development of a Practical and Reliable Large-Scale Synthesis of 2,6-Diamino-4-bromopyridine 2002 ·Organic Process Research & Development ·Matthias Nettekoven,(unknown)	19
17	Combinatorial synthesis of libraries of indole derivatives 2001 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Nettekoven	12
18	Combinatorial Synthesis of 5-Aryl-[1,2,4]-triazolo-[1,5-a]-pyridine Derivatives as Potential Inhibitors of the Adenosine 2A Receptor 2001 ·Synlett ·Matthias Nettekoven	23
19	NEW POLYETHYLENE GLYCOL POLYMERS AS KETAL PROTECTING GROUPS – A POLYMER SUPPORTED APPROACH TO SYMMETRICALLY SUBSTITUTED SPIROKETALS 2001 ·Synthetic Communications ·Rainer Haag,Andrew G. Leach,Steven V. Ley,Matthias Nettekoven,(unknown)	14
20	Synthesis of enantiomerically pure 4-alkylsubstituted tryptophan derivatives by a combination of organometallic reactions with enantioselective enzymatic transformations 1995 ·Tetrahedron Letters ·Matthias Nettekoven,(unknown),Herbert Waldmann	15

About Matthias Nettekoven

Matthias Nettekoven is a scholar working on Organic Chemistry, Endocrine and Autonomic Systems and Cellular and Molecular Neuroscience, having authored 35 papers that have together received 663 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (12 papers), Synthesis and Biological Evaluation (7 papers) and Chemical Synthesis and Analysis (6 papers). The work is most often cited by research in Endocrine and Autonomic Systems (85 citations), Organic Chemistry (309 citations) and Pharmaceutical Science (41 citations). Matthias Nettekoven has collaborated with scholars based in Switzerland, Germany and Canada. Frequent co-authors include Gisbert Schneider, Wolfgang Guba, Andrew W. Thomas, Henner Knust, Olivier Roche, Sébastien Schmitt, Mark Rogers‐Evans, Werner Neidhart, Christoph Ullmer and Diego A. Fort. Their work appears in journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact